Cellectricon is a leading provider of neurobiology research services, specializing in the discovery and development of drugs for peripheral and central nervous system diseases. With a focus on in vitro research, they offer innovative approaches and cutting-edge technologies to accelerate the drug discovery process, from target identification to lead optimization.
Combining drug discovery expertise, disease area knowledge, and advanced assay development, Cellectricon creates complex disease models and assays for functional and morphological screening, providing mechanistic understanding and novel insights into disease biology. Their mission is to advance the field of neuroscience research and enable successful drug discovery programs for their clients.
Generated from the website